164 related articles for article (PubMed ID: 21284054)
1. Reirradiation with intensity-modulated radiotherapy in recurrent head and neck cancer.
Zwicker F; Roeder F; Hauswald H; Thieke C; Timke C; Schlegel W; Debus J; Münter MW; Huber PE
Head Neck; 2011 Dec; 33(12):1695-702. PubMed ID: 21284054
[TBL] [Abstract][Full Text] [Related]
2. High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: disease control, survival and toxicity.
Duprez F; Berwouts D; Madani I; Bonte K; Boterberg T; De Gersem W; Deron P; Huvenne W; De Neve W
Radiother Oncol; 2014 Jun; 111(3):388-92. PubMed ID: 24998706
[TBL] [Abstract][Full Text] [Related]
3. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.
Sher DJ; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Balboni T; Allen A; Tishler RB
Cancer; 2010 Oct; 116(20):4761-8. PubMed ID: 20572036
[TBL] [Abstract][Full Text] [Related]
5. Chemo-reirradiation in persistent/recurrent head and neck cancers.
Nagar YS; Singh S; Datta NR
Jpn J Clin Oncol; 2004 Feb; 34(2):61-8. PubMed ID: 15067097
[TBL] [Abstract][Full Text] [Related]
6. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study.
Kakria A; Rawat S; Bhutani R; Gupta G; Devnani B; Wahi IK; Ahlawat P
Asia Pac J Clin Oncol; 2015 Jun; 11(2):129-34. PubMed ID: 25132076
[TBL] [Abstract][Full Text] [Related]
8. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.
McAvoy S; Ciura K; Wei C; Rineer J; Liao Z; Chang JY; Palmer MB; Cox JD; Komaki R; Gomez DR
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):819-27. PubMed ID: 25220718
[TBL] [Abstract][Full Text] [Related]
9. Prospective trial of high-dose reirradiation using daily image guidance with intensity-modulated radiotherapy for recurrent and second primary head-and-neck cancer.
Chen AM; Farwell DG; Luu Q; Cheng S; Donald PJ; Purdy JA
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):669-76. PubMed ID: 20547443
[TBL] [Abstract][Full Text] [Related]
10. Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer.
Rusthoven KE; Feigenberg SJ; Raben D; Kane M; Song JI; Nicolaou N; Mehra R; Burtness B; Ridge J; Swing R; Lango M; Cohen R; Jimeno A; Chen C
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1020-5. PubMed ID: 20231078
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
Duprez F; Madani I; Bonte K; Boterberg T; Vakaet L; Derie C; De Gersem W; De Neve W
Radiother Oncol; 2009 Dec; 93(3):563-9. PubMed ID: 19919885
[TBL] [Abstract][Full Text] [Related]
12. IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer.
Zwicker F; Roeder F; Thieke C; Timke C; Münter MW; Huber PE; Debus J
Strahlenther Onkol; 2011 Jan; 187(1):32-8. PubMed ID: 21234529
[TBL] [Abstract][Full Text] [Related]
13. Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis.
Caudell JJ; Ward MC; Riaz N; Zakem SJ; Awan MJ; Dunlap NE; Isrow D; Hassanzadeh C; Vargo JA; Heron DE; Marcrom S; Boggs DH; Reddy CA; Dault J; Bonner JA; Higgins KA; Beitler JJ; Koyfman SA; Machtay M; Yao M; Trotti AM; Siddiqui F; Lee NY;
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):606-617. PubMed ID: 29413274
[TBL] [Abstract][Full Text] [Related]
14. Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck.
Kharofa J; Choong N; Wang D; Firat S; Schultz C; Sadasiwan C; Wong S
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):690-5. PubMed ID: 22112556
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
16. Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial.
Hehr T; Classen J; Belka C; Welz S; Schäfer J; Koitschev A; Bamberg M; Budach W
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1423-31. PubMed ID: 15817346
[TBL] [Abstract][Full Text] [Related]
17. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
[TBL] [Abstract][Full Text] [Related]
18. [Hyperfractionated reirradiation after salvage surgery in cervico-facial carcinoma. Result of a pilot study in 14 patients].
Benchalal M; Bachaud JM; François P; Alzieu C; Giraud P; David JM; Daly-Schveitzer N
Cancer Radiother; 1997; 1(1):68-73. PubMed ID: 9265536
[TBL] [Abstract][Full Text] [Related]
19. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
20. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
